Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PLAIV H1N1 Vaccine Safety and Immunogenicity in Healthy Thais
NCT01666262Phase 2Completed
- Sponsor
- Mahidol University
- Start
- Sep 2009
- Modality
- Live Attenuated Vaccines
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of A/17/California/2009/38 (H1N1) in Influenza A H1N1 (H1N1), sponsored by Mahidol University. Primary endpoint: Systemic reaction and local reaction at 1.5 years. Started Sep 2009; status: completed.
02
Drugs
A/17/California/2009/38 (H1N1)
03
Conditions
Influenza A H1N1 (H1N1)
Beyond the preview
Go deeper on NCT01666262.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01666262.